Effectiveness of physiotherapy interventions on improving quality of life, total neuropathy score, strength and reducing pain in cancer survivors suffering from chemotherapy-induced peripheral neuropathy – a systematic review

References

• Pulumati A, Pulumati A, Dwarakanath BS, et al. Technological advancements in cancer diagnostics: improvements and limitations. Cancer Rep. 2023;6(2):e1764.
   Google Scholar
• Zajączkowska R, Kocot-Kępska M, Leppert W, et al. Mechanisms of chemotherapy-induced peripheral neuropathy. Int J Mol Sci. 2019;20(6):1451. doi: 10.3390/ijms20061451.
   PubMed Web of Science ®Google Scholar
• Staff NP, Grisold A, Grisold W, et al. Chemotherapy-induced peripheral neuropathy: a current review. Ann Neurol. 2017;81(6):772–781. doi: 10.1002/ana.24951.
   PubMed Web of Science ®Google Scholar
• Colvin LA. Chemotherapy-induced peripheral neuropathy (CIPN): where are we now? Pain . 2019;160 (Suppl 1): S1–S10. doi: 10.1097/j.pain.0000000000001540.
   PubMedGoogle Scholar
• Areti A, Yerra VG, Naidu VGM, et al. Oxidative stress and nerve damage: role in chemotherapy induced peripheral neuropathy. Redox Biol. 2014;2:289–295. doi: 10.1016/j.redox.2014.01.006.
   PubMed Web of Science ®Google Scholar
• McWhinney SR, Goldberg RM, McLeod HL. Platinum neurotoxicity pharmacogenetics. Mol Cancer Ther. 2009;8(1):10–16. doi: 10.1158/1535-7163.MCT-08-0840.
   PubMed Web of Science ®Google Scholar
• Starobova H, Vetter I. Pathophysiology of chemotherapy-induced peripheral neuropathy. Front Mol Neurosci. 2017;10:174. doi: 10.3389/fnmol.2017.00174.
   PubMed Web of Science ®Google Scholar
• Park SB, Cetinkaya-Fisgin A, Argyriou AA, et al. Axonal degeneration in chemotherapy-induced peripheral neurotoxicity: clinical and experimental evidence. J Neurol Neurosurg Psychiatry. 2023; doi: 10.1136/jnnp-2021-328323.
   Web of Science ®Google Scholar
• Han Y, Smith MTP. Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN). Front Pharmacol. 2013;4:156. doi: 10.3389/fphar.2013.00156.
   PubMed Web of Science ®Google Scholar
• Niemand EA, Cochrane ME, Eksteen CA. Physiotherapy management of chemotherapy-induced peripheral neuropathy in pretoria, South Africa. South Afr J Physiother. 2020;76(1):1482.
   PubMed Web of Science ®Google Scholar
• Whalen LB, Wright WZ, Kundur P, et al. Beneficial effects of exercise on chemotherapy-induced peripheral neuropathy and sleep disturbance: a review of literature and proposed mechanisms. Gynecol Oncol Rep. 2022;39:100927.
   PubMed Web of Science ®Google Scholar
• Dickersin K, Chan S, Chalmers TC, et al. Publication bias and clinical trials. Control Clin Trials. 1987;8(4):343–353.
   PubMedGoogle Scholar
• Berger VW, Alperson SY. A general framework for the evaluation of clinical trial quality. Rev Recent Clin Trials. 2009;4(2):79–88. doi: 10.2174/157488709788186021.
   PubMedGoogle Scholar
• Paci M, Bianchini C, Baccini M. Reliability of the PEDro scale: comparison between trials published in predatory and non-predatory journals. Arch Physiother. 2022;12(1):10. doi: 10.1186/s40945-022-00133-6.
   PubMedGoogle Scholar
• Şimşek NY, Demir A. Cold application and exercise on development of peripheral neuropathy during taxane chemotherapy in breast cancer patients: a randomized controlled trial. Asia Pac J Oncol Nurs. 2021;824(3):255–266. doi: 10.4103/apjon.apjon-2075.
   Google Scholar
• PA A, KV B, MA G, et al. The effect of photobiomodulation on chemotherapy-induced peripheral neuropathy: a randomized, sham-controlled clinical trial. Gynecol Oncol. 2017;144(1):159–166.
   PubMed Web of Science ®Google Scholar
• Andersen Hammond E, Pitz M, Steinfeld K, et al. An exploratory randomized trial of physical therapy for the treatment of chemotherapy-induced peripheral neuropathy. Neurorehabil Neural Repair. 2020;34(3):235–246.
   PubMed Web of Science ®Google Scholar
• Dhawan S, Andrews R, Kumar L, et al. A randomized controlled trial to assess the effectiveness of muscle strengthening and balancing exercises on chemotherapy-induced peripheral neuropathic pain and quality of life among cancer patients. Cancer Nurs. 2020;43(0 ):269–280.
   Google Scholar
• Bland KA, Kirkham AA, Bovard J, et al. Effect of exercise on taxane chemotherapy-induced peripheral neuropathy in women with breast cancer: a randomized controlled trial. Clin Breast Cancer. 2019;19( 6):411–422.
   PubMed Web of Science ®Google Scholar
• Kneis S, Wehrle A, Müller J, et al. It’s never too late – balance and endurance training improves functional performance, quality of life, and alleviates neuropathic symptoms in cancer survivors suffering from chemotherapy-induced peripheral neuropathy: results of a randomized controlled trial. BMC Cancer. 2019;19( 1):414.
   PubMedGoogle Scholar
• Kleckner IR, Kamen C, Gewandter JS, et al. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial. Support Care Cancer. 2018; 26( 4):1019–1028.
   PubMed Web of Science ®Google Scholar
• Zimmer P, Trebing S, Timmers-Trebing U, et al. Eight-week, multimodal exercise counteracts a progress of chemotherapy-induced peripheral neuropathy and improves balance and strength in metastasized colorectal cancer patients: a randomized controlled trial. Support Care Cancer. 2018;26( 2):615–624.
   PubMed Web of Science ®Google Scholar
• Song S-Y, Park J-H, Lee JS, et al. A randomized, placebo-controlled trial evaluating changes in peripheral neuropathy and quality of life by using low-frequency electrostimulation on breast cancer patients treated with chemotherapy. Integr Cancer Ther. 2020;19:1534735420925519. doi: 10.1177/1534735420925519.
   Web of Science ®Google Scholar
• Müller J, Weiler M, Schneeweiss A, et al. Preventive effect of sensorimotor exercise and resistance training on chemotherapy-induced peripheral neuropathy: a randomised-controlled trial. Br J Cancer. 2021;125(7):955–965.
   PubMed Web of Science ®Google Scholar